- $11.21bn
- $12.75bn
- $31.96bn
- 90
- 95
- 91
- 100
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,487 | 11,184 | 18,389 | 38,205 | 31,964 |
Cost of Revenue | |||||
Gross Profit | 3,702 | 1,946 | 3,132 | 7,472 | 5,910 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16,210 | 11,862 | 17,588 | 34,135 | 29,762 |
Operating Profit | 1,277 | -679 | 801 | 4,070 | 2,203 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,172 | -747 | 787 | 3,936 | 2,153 |
Provision for Income Taxes | |||||
Net Income After Taxes | 872 | -515 | 663 | 3,041 | 1,711 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 772 | -601 | 558 | 2,923 | 1,590 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 771 | -603 | 551 | 2,893 | 1,576 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.29 | -1.87 | 2.9 | 14.4 | 8.34 |
Dividends per Share |